Prognostic factors of patients with pathologic stage I lung adenocarcinoma

Affiliations

Editorial

Ying-Yi Chen et al. J Thorac Dis. 2018 Apr.

. 2018 Apr;10(Suppl 9):S1115-S1118.

doi: 10.21037/jtd.2018.04.37.

¹ Division of Thoracic Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Lymph node micrometastasis in N stage: a call for more evidence.
Ren Y, Dai C, Xie H, She Y, Su H, Chen C. Ren Y, et al. J Thorac Dis. 2018 Jul;10(Suppl 18):S2219-S2220. doi: 10.21037/jtd.2018.06.57. J Thorac Dis. 2018. PMID: 30123567 Free PMC article. No abstract available.

Relationship of Lymph Node Micrometastasis and Micropapillary Component and Their Joint Influence on Prognosis of Patients With Stage I Lung Adenocarcinoma.
Dai C, Xie H, Kadeer X, Su H, Xie D, Ren Y, She Y, Zhu E, Fan Z, Chen T, Qin L, Zheng H, Zhang L, Jiang G, Wu C, Chen C. Dai C, et al. Am J Surg Pathol. 2017 Sep;41(9):1212-1220. doi: 10.1097/PAS.0000000000000901. Am J Surg Pathol. 2017. PMID: 28692600

1. Goldstraw P, Chansky K, Crowley J, et al. The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer. J Thorac Oncol 2016;11:39-51. 10.1016/j.jtho.2015.09.009 - DOI - PubMed
1. Chen YY, Huang TW, Chang H, et al. Optimal delivery of follow-up care following pulmonary lobectomy for lung cancer. Lung Cancer (Auckl) 2016;7:29-34. - PMC - PubMed
1. Hsu CH, Tseng CH, Chiang CJ, et al. Characteristics of young lung cancer: Analysis of Taiwan's nationwide lung cancer registry focusing on epidermal growth factor receptor mutation and smoking status. Oncotarget 2016;7:46628-35. 10.18632/oncotarget.9338 - DOI - PMC - PubMed
1. Yang Y, Mao Y, Yang L, et al. Prognostic factors in curatively resected pathological stage I lung adenocarcinoma. J Thorac Dis 2017;9:5267-77. 10.21037/jtd.2017.11.65 - DOI - PMC - PubMed
1. Yi E, Bae MK, Cho S, et al. Pathological prognostic factors of recurrence in early stage lung adenocarcinoma. ANZ J Surg 2018;88:327-31. 10.1111/ans.14033 - DOI - PubMed